RAP 0.00% 20.5¢ resapp health limited

Conference Call Summary, page-302

  1. 4,198 Posts.
    lightbulb Created with Sketch. 1331
    "People should also know that the Bronchiolitis trials made the FDA 75% PPA and NPA cut, so that alone qualifies for FDA application."

    This.

    http://www.mayoclinic.org/diseases-conditions/bronchiolitis/home/ovc-20201572
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.